SUMMARY
SUMMARY The synaptic release of glutamate evokes in astrocytes periodic increases in the intracellular calcium concentration ([Ca
] i ), due to activation of metabotropic glutamate receptors (mGluRs). The frequency of these [Ca 2+ ] i oscillations is controlled by the level of neuronal activity, indicating that they represent a specific, frequency-coded signaling system of neuron-to-astrocyte communication.
We recently found that neuronal activity-dependent [Ca 2+ ] i oscillations in astrocytes are the main signal that regulates the coupling between neuronal activity and blood flow, the so-called functional hyperemia. Prostaglandins ] i changes. This finely tuned release of PGE 2 from astrocytes provides a coherent mechanistic background for the role of these glial cells in functional hyperemia.
INTRODUCTION
Since their early description, astrocytes were supposed to assist neurons in their function but, probably due to their inability to fire action potentials, they were never thought to actively participate in information processing in the brain. However, recent observations revealed their ability to respond to the synaptic release of neurotransmitters with [Ca 2+ ] i elevations (Porter & McCarthy, 1995; Pasti et al., 1997) , mainly mediated by the activation of group I metabotropic glutamate receptor (mGluR) (Pasti et al., 1997) , and GABAb receptors (Kang et al., 1998) , both linked to intracellular calcium mobilization. Neurotransmitter-mediated calcium elevations were proposed to represent a calcium-based form of excitability in astrocytes (Smith, 1994 ).
An important property of astrocyte [Ca 2+ ] i oscillations triggered by synaptically released glutamate is that they are tunable in frequency according to the level of neuronal activity: an increase in the intensity of stimulation applied to neuronal afferents results in a parallel increase in the frequency of [Ca 2+ ] i oscillations in astrocytes (Pasti et al., 1997) . Glutamate-mediated neuron-to-astrocyte signaling may thus represent a refined communication system which allows neurons to transfer to astrocytes information on the level of their activity (Carmignoto, 2000) . What type of functional event in the brain may depend on this neuron-to-astrocyte signaling? We recently identified a precise functional significance for this pathway in the control of cerebral microcirculation. We found that mGluR-mediated [Ca 2+ ] i oscillations, activated in astrocytes by synaptically released glutamate, are central for the coupling between neuronal activity and blood flow, the so-called functional hyperemia (Zonta et al., 2003) . Evidence has also been obtained indicating that arachidonic acid metabolites of the cyclooxygenase (COX) pathway play a major role in the astrocyte control of vascular tone.
Astrocytes are well known to represent a major source of prostanoids in the brain, under both physiological and pathological conditions (Bezzi et al., 1998; Hirst et al., 1999) , but whether or not [Ca 2+ ] i oscillations can regulate PG release from these cells and what spatio-temporal properties this release have, are issues which are not defined yet. The principal aim of the present study was to investigate whether mGluR-mediated [Ca 2+ ] i oscillations in astrocytes can control the pulsatile release from these cells of a prostanoid with vasodilating properties, such as the prostaglandin (PG) E 2 .
In view of the wide array of PG actions in the brain, the characterization of the rules governing PG release from these glial cells has additional motives of interest. The synthesis of prostaglandin in these cells as well as in other cell types, depends on the enzymatic activity of COX on its substrate arachidonic acid, which is released from phospholipids by the Ca 2+ -dependent enzyme phospholipase A 2 . The Ca 2+ dependency of PG production raises the question of whether a cell integrates the Ca 2+ signals generating a sustained PG synthesis and release, or retains their temporal coding resulting in a release that faithfully follows the kinetics and general pattern of the [Ca 2+ ] i changes. All the studies designed to analyze the synthesis and/or release of COX products in eucaryotic cells failed to provide information about the spatio-temporal features of this release, since they were performed either on cell homogenates (Seregi et al., 1987; Amruthesh et al., 1993) , or through off-line measurements in cell population (Bezzi et al., 1998) . Our experimental approach allows us to monitor the process of PG release at the level of single, living cells. We here provide evidence that activation of mGluRs controls the release of PGs from astrocytes, and that this release is pulsatile and synchronous with mGluR-mediated [Ca 2+ ] i oscillations.
METHODS

Cell cultures.
All experimental procedures were in strict accordance with the Italian and EU regulation on animal welfare, and previously authorized by the Italian Ministry of Health. Neonatal Wistar rats were deeply anaesthesized by a cocktail of xilazina, tiletamina and zolazepan and then sacrificed by cervical dislocation. Primary cultures of cortical astrocytes were prepared as previously described (Pasti et al., 1995) . Fourteen days after plating, cultured cells were subjected to 15 hrs of continuous shaking and then incubated for 5 min with 0.2% trypsin. Detached cells were collected and replated on poly-L-lysine coated 24-mm-diameter coverslips. In all experiments, 2-weeks-old astrocyte secondary cultures were used. The absence of contaminating neurons and microglia in these cultures was assessed by immunocytochemistry with anti-200-kDa neurofilament antibody to identify neurons (Vitadello & Denis-Donini, 1990) , and by specific staining of microglial cells with a FITC-labeled lectin from Lycopersicon Esculentum (Sigma) (Boucsein et al., 2000) , while astrocytes were identified using anti-GFAP antibody (Boehringer). Human embryonic kidney (HEK) 293 cells (American Type Culture Collection, Manassas, VA) were co-transfected with either the cDNAs encoding for the NMDAR subunits 1-2A and GFP (Pasti et al., 2001) , in the presence of 2 mM kynurenic acid and 500 µM ketamine, or the cDNA of the human EP 1 receptor (Funk et al., 1993) (Pasti et al., 2001) . HEK cells were trypsinized after 7-9 hrs of transfection and replated on astrocyte cultures. For confocal microscope experiments, after 1-3 days, co-cultures were incubated with the Ca 2+ indicator Indo-1 AM (5 µM) at 37°C for 40-50 min in the presence of 0.04% pluronic and 200 µM sulfinpyrazone. Clones of HEK cells were obtained by limiting dilution from wtHEK cells, and a clone which did not display any [Ca 2+ ] i increase upon stimulation with PGE 2 was isolated (HEK U ). L-quisqualate and 1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) were from Tocris Cookson Ltd. (Bristol, UK). PGE 2 , SC19220 and AH6809 were from BioMol (Plymouth Meeting, PA); indomethacin was from Sigma.
Confocal microscopy.
Digital fluorescence microscopy (Nikon, RCM8000) was used for monitoring the change in Indo-1 emission after cell loading with Indo-1 AM (Molecular Probes, Eugene, OR) as previously described (Pasti et al., 2001) . After excitation at 351 nm wavelength, the emitted light was separated into its two components (405 and 485 nm), and the ratio (R405/485) was displayed as a pseudocolor scale. During experiments, cultured cells were continuously perfused (1.5-3 ml/min) with an extracellular solution, consisting of (in mM): 145 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 1 Na 3 PO 4 , 5.5 glucose, 10 HEPES and 0.2 sulfinpyrazone, at pH 7.4 with NaOH, at 32°C. Sampling rate was 2s. Less than 6s of delay between [Ca 2+ ] i increases in the astrocyte and those in the adjacent transfected HEK cell were considered indicative of temporal correlation.
Electrophysiology
Standard procedures for pipette preparation and patch-clamp recordings in the wholecell configuration were used. During experiments cells were continuously perfused with the same extracellular solution (without sulfinpyrazone) used for confocal microscope experiments. The recording pipette contained (in mM): 145 K-gluconate , 2 MgCl 2 , 5 EGTA, 2 Na 2 ATP, 0.2 NaGTP and 10 HEPES at pH 7.2 with KOH. Two patch-clamp amplifiers (Axopatch 200B, Axon Instrument) were grounded to a common ground point and were used for voltage-clamp recordings. Current signals were filtered at 1 KHz, digitized at 5 KHz by the interface Digidata1200A and analyzed by PCLAMP-8 software (Axon Instrument). Hyperpolarizing and depolarizing voltage pulses (100 ms duration) from a holding potential of -70 mV were delivered every 2 s. Simultaneous dual patch-clamp recordings were performed from pairs of cells consisting of an astrocyte and a nearby GFP fluorescent HEK cell transfected with the prostaglandin receptor EP1.
RESULTS
Astrocyte stimulation triggers D-AP5 insensitive responses in NMDAR-transfected HEK cells.
To investigate the release of specific molecules from astrocytes, we recently developed an experimental model based on Human Embryonic Kidney (HEK293) cells transiently transfected with the specific receptor for the molecule under study (Pasti et al., 2001) . Co-transfection with a green fluorescent protein (GFP) ensures identification of the cells expressing the receptor. When plated on cultured astrocytes, each transfected HEK cell acts as a biosensor of the release of the molecule of interest. This release can be revealed in the sensor cell by monitoring, through Ca 2+ imaging techniques, the [Ca 2+ ] i changes and/or, through patch clamp recordings, the current(s) that may result from the activation of the transfected receptor. After loading of the HEK-astrocyte cultures with a Ca 2+ indicator, it is thus possible to simultaneously monitor both the [Ca 2+ ] i increases in the astrocyte and, indirectly through the [Ca 2+ ] i rise in the HEK cell, the release event. Detailed information can therefore be obtained on the relationship between the spatio-temporal features of the [Ca 2+ ] i elevations in astrocytes and the process of release.
By employing HEK cells transfected with the ionotropic glutamate receptor NMDA (NR-GFP HEK cells) (Pasti et al., 2001) , we previously showed that [Ca 2+ ] i oscillations triggered by L-quisqualate, an agonist of both mGlu and AMPA receptors, regulate a SNARE protein-dependent pulsatile release of glutamate from astrocytes. However, in 36.2% (17 of 47) of responsive NR-GFP HEK cells, the NMDAR antagonist D-2-amino-5-phosphonopentanoic acid (D-AP5), failed to block [Ca 2+ ] i elevations in sensor cells (Fig.1A) . To investigate whether astrocytes release another molecule that acts on receptors endogenously expressed in sensor cells, HEK cells solely transfected with GFP (GFP-HEK) were plated on astrocytes. A number of GFP-HEK cells (27.7%, 5 of 18) showed [Ca 2+ ] i elevations upon astrocyte stimulation, demonstrating that a subpopulation of HEK cells (and thus also of NR-GFP HEK cells) is equipped with a receptor sensing an astrocyte-derived molecule other than glutamate.
Among the various Ca 2+ mobilizing compounds that can be released by activated astrocytes, PGs appear as good candidates. In fact, astrocytes can release PGE 2 upon activation of glutamatergic receptors (Bezzi et al., 1998 ). An initial observation that supports our hypothesis is that a subpopulation of wild type (wt) HEK cells (43.6%, 48 of 110) display [Ca 2+ ] i elevations when directly stimulated with PGE 2 . To get further insights into the nature of the molecule released by astrocytes, we used the COX inhibitor indomethacin to block the synthesis of PGs. Cultures, in which GFP-HEK cells displayed [Ca 2+ ] i increases correlated with those induced by L-quisqualate in astrocytes, were incubated for 40 min with 5 µM indomethacin. Under these conditions, no [Ca 2+ ] i elevations were observed in GFP-HEK cells upon a second challenge with Lquisqualate (n=4, Fig.1B ). L-quisqualate triggered in astrocytes [Ca 2+ ] i increases of comparable amplitude (0.39 ± 0.03 and 0.42 ± 0.04, before and after indomethacin, respectively, mean R405/485 change ± SEM; n=27; Fig. 1C (Fig.2A, panel ] i elevations, temporally correlated with those observed in the astrocyte ( Fig.3A and 3B ] i peaks more efficiently triggered the release.
To investigate the possible existence of gap junctional coupling between astrocytes and EP 1 -EGFP HEK U cells, we performed whole-cell, patch clamp recordings from pairs of cells consisting of an astrocyte and an adjacent EP 1 -EGFP HEK U cell. Voltage pulses, which were always applied to either the astrocyte and the EP 1 -EGFP HEK U cell, were never observed to spread to the other cell ( Supplementary Fig.1A ). In all pairs (n=5), the stimulation protocol was repetitively applied for at least 20 min. In three pairs the voltage steps were also applied after stimulation with 20 µM t-ACPD ( Supplementary  Fig.1B ). We never observed signs of electrical coupling between the astrocyte and the EP 1 -EGFP HEK U cell.
The commercially available EP 1 R antagonists SC19220 and AH6809 (10-100 µM), failed to inhibit the [Ca 2+ ] i response of EP 1 -EGFP HEK U to astrocyte stimulation. However, these antagonists, applied at the highest concentration (100 µM), were able to block the response of EP 1 -EGFP HEK U to the direct stimulation with PGE 2 only at PGE 2 concentration not higher than 1 nM. Consequently, they could not be considered reliable pharmacological tools to effectively block the EP 1 receptors.
To prove that the presence of the PG receptor EP 1 is essential to HEK U cells for sensing the molecule released from astrocytes, we compared the percentage of EP 1 -EGFP HEK U responding to astrocyte stimulation, with that of HEK U not transfected with EP 1 receptor (EGFP HEK U ). When plated on astrocytes, EGFP HEK U failed, with one exception, to respond to astrocytic oscillations (n=74, Fig.3A) . Consistently, inhibition of PG synthesis with indomethacin blocked [Ca 2+ ] i elevations in EP 1 -EGFP HEK U following astrocyte stimulation, while washout of the inhibitor allowed the recovery of the response (n=5, Fig.3B ).
Run down of the system is unlikely to account for this lack of response in EP 1 -EGFP HEK U cells since in cultures not incubated with indomethacin two subsequent challenges with either L-quisqualate or t-ACPD, triggered comparable responses in the great majority (18 of 21; 86%) of EP 1 -EGFP HEK U cells. Also noteworthy is that in nine EP 1 -EGFP HEK U cells we performed a 3rd challenge and found responses in 8 cells.
DISCUSSION PG release from astrocytes is pulsatile.
Over the last years, several experimental evidences demonstrated that the stimulation of mGluRs induces Ca 2+ -dependent production of arachidonic acid metabolites including PGE 2 (Dumuis et al., 1990; Bezzi et al., 1998) , but the kinetics and spatial aspects of such a release at the single cell level could not be determined since prostanoids were biochemically measured in the supernatant of cell cultures. Our experimental approach allows to investigate the process of PG release at the single cell level. We used HEK cells transfected with the specific PGE 2 receptor EP 1 as biosensors of PG release from astrocytes. To stimulate [Ca 2+ ] i elevations in astrocytes we could used agonists of GluRs such as L-quisqualate and t-ACPD since HEK cells express neither ionotropic nor metabotropic glutamate receptors (Pasti et al., 2001) . The key finding of the present work is that the release of a PG, possibly PGE 2 , from activated astrocytes is oscillatory in nature, and synchronous with the oscillations of [Ca 2+ ] i .
The first hint that [Ca 2+ ] i oscillations in astrocytes could lead to the pulsatile release of a prostanoid, in turn capable of inducing [Ca 2+ ] i rises in the adjacent reporter cell, came from the observation that upon astrocyte stimulation, NMDAR-transfected HEK cells showed [Ca 2+ ] i increases insensitive to the NMDAR antagonist D-AP5 (Pasti et al., 2001) . [Ca 2+ ] i elevations triggered by astrocyte stimulation were also observed in HEK cells not expressing the NMDAR and were found to be abolished after cell preincubation with the COX inhibitor indomethacin. However, we previously showed that the release of glutamate from astrocytes depends on PG formation (Bezzi et al., 1998) . Therefore, it could not be excluded that the synthesis and/or the release of the factor that causes D-AP5-insensitive responses in NMDAR-transfected HEK cells were also dependent on a COX product. In other words, the results from indomethacin experiments does not provide unambigous evidence that a PG is the factor that directly acts in the sensor cell to trigger the Ca 2+ response. Further difficulties for the identification of the prostanoid nature of the molecule released from astrocytes, depend on the fact that the available antagonists of EP 1 receptors, such as SC19220 and AH6809 (Funk et al., 1993) , are largely unsatisfactory. In fact, at the highest concentration that we could use (100 µM), these inhibitors antagonized the action of PGE 2 , applied directly to EP 1 -expressing HEK cells (EP 1 -EGFP HEK U ), only when the PG was used at concentration 10 5 fold lower. The failure of these antagonists to inhibit the [Ca 2+ ] i response of EP 1 -EGFP HEK U to astrocyte stimulation could simply indicate that the local PG concentration is higher than 1 nM.
It was the use of HEK U (a PGE 2 unresponsive HEK cell clone) that ultimately allowed us to directly show that the ability of wt HEK cells to respond to astrocyte stimulation depends on the presence of a PG receptor, and thus on the release from astrocytes of a PG. Indeed, the response observed in wt HEK cells was absent in HEK U cells, but it was restored after transfection of these cells with the EP 1 receptor.
The [Ca
2+
] i elevations in EP 1 -EGFP HEK U cells in response to astrocyte stimulation could not be attributed to gap junction communication between astrocytes and the sensor cell. In prolonged patch-clamp recordings from pairs of cells consisting of an astrocyte and an adjacent EP 1 -EGFP HEK U , we never observed evidence for electrical coupling between these two cells. These observations confirm results from previous experiments in which Lucifer Yellow included in a patch pipette was not found to diffuse from patched HEK cells to sorrounding astrocytes or from patched astrocytes to HEK cells (Pasti et al., 2001 ).
The [Ca
2+
] i elevations observed in the sensor HEK cells were found to be oscillatory. Two possible mechanisms could be envisaged: i) a single episode of PG release occurs upon astrocyte stimulation, and the evoked [Ca 2+ ] i oscillations in HEK cells are due to an intrinsic feature of EP 1 R activation; ii) PG release from astrocytes is pulsatile and drives [Ca 2+ ] i oscillations in the sensor HEK cells. Two lines of evidence argue in favour of the second possibility: i) when high doses of mGluR agonists were used, the [Ca 2+ ] i change in the astrocytes was composed by a single [Ca 2+ ] i peak followed by a sustained plateau; under these conditions, in most of the HEK cells only a single episode of [Ca 2+ ] i increase was observed; ii) the great majority (84%) of [Ca 2+ ] i elevations observed in the sensor cells were temporally correlated with a [ Ca   2+ ] i peak in a nearby astrocyte. Taken together, these observations suggest that either the activation of phospholipase A 2 and/or the release process faithfully follow the kinetics and general pattern of the [Ca 2+ ] i changes. While the frequency of [Ca 2+ ] i oscillations controls the timing of the release, the amplitude of each [Ca 2+ ] i peak controls its efficacy. Last but not least, PG release from astrocytes is extremely fast, given that the delay between the [Ca 2+ ] i peak of the astrocyte and that in the sensor cells can be as short as 2 s.
In a number of EP 1 -EGFP HEK U cells (16%), [Ca 2+ ] i elevations were not temporally correlated with [Ca 2+ ] i elevations in nearby astrocytes. These responses may be due to the release of PGs from astrocytic processes which could not be visualized because they were on a different focal plane. Alternatively, these uncorrelated [Ca 2+ ] i elevations may be due to slow diffusion of PGs released from astrocytes located faraway from the sensor cells. The consequent delayed activation of EP 1 receptors may account for the lack of correlation.
Astrocytes can display [Ca 2+ ] i oscillations in response to the synaptic release of the inhibitory neurotransmitter GABA (Kang et al., 1998) , raising the possibility that [Ca 2+ ] i elevations triggered in astrocytes by signaling molecules other than glutamate might also trigger PG release. Additional experiments are necessary to address this issue.
Possible functional roles of PG release from astrocytes.
PGs are known to affect diverse phenomena in the CNS, such as neuronal transmission (Sekiyama et al., 1995; Borgland et al., 2002) , vascular tone control (Narumiya et al., 1999) and inflammation (Davies et al., 1984) , as well as to be involved in neurodegenerative diseases, including prion infections, HIV-dementia and Alzheimer's disease (Griffin et al., 1994) (Williams et al., 1997) (Combs et al., 2000; Yasojima et al., 2001) . Our finding that PG release from astrocytes is regulated by the frequency of [Ca 2+ ] i oscillations provides a novel perspective for identifying and characterizing the involvement of astrocytic PG release in one or more of these PG actions.
Given that the frequency of [Ca 2+ ] i oscillations in astrocytes is controlled by neuronal activity (Pasti et al., 1997) , PG release from astrocytes could also be under the direct control of neurons. This view finds a strict functional correlation with our recent data describing a distinct astrocyte role in the control of cerebral microcirculation. We found that the coupling between neuronal activity and blood flow, the so-called functional hyperemia, mainly depends on mGluR-mediated [Ca 2+ ] i oscillations in astrocytes and on a COX product. Our present finding suggests that the COX product mediating vasodilation is released from astrocytes. Indeed, the same mGluR-mediated oscillations that control neuronal activity-dependent vasodilation, control the pulsatile release from cultured astrocytes of a PG with vasodilating properties. The PGs that can activate the PG receptor subtype in sensor cells, i.e. PGE 2 and, with a lower affinity, PGI 2 and PGE 1 (Funk et al., 1993) (Narumiya et al., 1999) , are in fact powerful vasodilators.
We recently provided evidence for a central role of astrocytes in functional hyperemia, i.e. the tight coupling between neuronal activity and blood flow (Zonta et al., 2003) . An important implication of the observations here reported is related to the time course of functional hyperemia. While there is a general agreement on the strict relationship existing between the timing for neuronal activity and that for the blood flow response, the molecules and mechanism(s) governing this temporal correlation are largely unknown. Indeed, the dilation of cerebral arterioles -that guarantees a blood flow increase in the region of high neuronal activity -is maintained as long as high neuronal activity is maintained. When synaptic activity returns to resting conditions, the blood flow in that region also returns to basal levels. We propose that the timing of this process is regulated by astrocyte [Ca 2+ ] i oscillations. The frequency and the duration of [Ca 2+ ] i oscillations in astrocytes, which are dynamically regulated by neuronal signalsset up the timing of PG release from these cells. This provide a coherent mechanistic background that may account for the timing of blood vessel responses to high neuronal activity. In other words, the pulsatility of PG release together with the the short halflife of this molecule, ensures that the dilating action of PG triggered by a [Ca 2+ ] i peak will soon vanish unless another [Ca 2+ ] i peak provides novel PG.
The dependence on frequency and duration of [Ca 2+ ] i oscillations may represent a general rule governing PG release. In view of the wide array of PG action and of the oscillatory nature often characterizing [Ca 2+ ] i signals in PG-producing cells, our observation is functional to a better understanding of the PG role in the brain. ] i responses upon astrocyte stimulation, for EP 1 -EGFP HEK U cells (n=148) and for EGFP HEK U cells (n=74). B, Kinetics of R405/485 changes in one astrocyte (black area) and in one adjacent EP 1 -EGFP HEK cell (grey area) upon three successive stimulation with t-ACPD 20µM. The second challenge was performed after 40 min incubation with indomethacin, and the third after 30 min washout of the inhibitor.
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